Mesoblast Ltd SEC filings MEOBF
Mesoblast Ltd has 598 filings in SEC EDGAR's recent list, going back to Nov 8, 2005. Its latest annual report, Form 20-F, was filed on Aug 27, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Jan 14, 2026 | — |
| F-3ASR | Registration statement | Dec 31, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 30, 2025 | — |
| 424B3 | Prospectus | Feb 12, 2025 | — |
| F-3/A | Amendment no. 1 to form f-3 | Feb 6, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Feb 5, 2025 | — |
| 424B3 | Prospectus | Dec 27, 2024 | — |
| F-3/A | Amendment no. 1 to form f-3 | Dec 23, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 13, 2024 | — |
| 424B3 | Prospectus | Apr 26, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Apr 16, 2024 | — |
| F-6 POS | Filing | Jan 5, 2024 | — |
| F-6 POS | Filing | Dec 22, 2023 | — |
| F-6 POS | Filing | Dec 22, 2023 | — |
| F-6 POS | Filing | Dec 21, 2023 | — |
| F-6EF | Filing | Jul 31, 2023 | — |
| 424B3 | Prospectus | May 26, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | May 18, 2023 | — |
| 424B3 | Prospectus | Apr 4, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 24, 2023 | — |
| 424B3 | Prospectus | Dec 30, 2022 | — |
| 424B3 | Prospectus | Dec 27, 2022 | — |
| S-8 POS | Post-effective amendment no. 1 to form s-8 | Dec 20, 2022 | — |
| S-8 POS | Post-effective amendment no. 1 to form s-8 | Dec 20, 2022 | — |
| S-8 POS | Post-effective amendment no. 1 to form s-8 | Dec 20, 2022 | — |
| S-8 POS | Post-effective amendment no. 1 to form s-8 | Dec 20, 2022 | — |
| S-8 POS | Post-effective amendment no. 1 to form s-8 | Dec 20, 2022 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 20, 2022 | — |
| POS AM | Post-effective amendment no. 1 to form f-3 | Dec 20, 2022 | — |
| S-8 | Employee stock plan registration | Sep 30, 2022 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 31, 2022 | — |
| F-3ASR | Automatic shelf registration statement | Jan 24, 2022 | — |
| S-8 | Employee stock plan registration | Dec 23, 2021 | — |
| F-3ASR | Registration statement | Apr 7, 2021 | — |
| F-3ASR | Automatic shelf registration statement | Mar 23, 2021 | — |
| S-8 | Employee stock plan registration | Jul 27, 2020 | — |
| S-8 | Employee stock plan registration | Oct 17, 2017 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 10, 2017 | — |
| S-8 | Employee stock plan registration | Apr 26, 2016 | — |
| 424B4 | Prospectus | Nov 13, 2015 | — |
| F-1MEF | Registration statement on form s-1 filed pursuant to rule 462(b) | Nov 12, 2015 | — |
| F-1/A | Amendment no. 2 to form f-1 | Nov 9, 2015 | — |
| F-1/A | Amendment no. 1 to form f-1 | Nov 6, 2015 | — |
| F-1 | Registration statement (foreign issuer) | Nov 2, 2015 | — |
| F-6 | Filing | Oct 9, 2015 | — |
| F-6 | Form f-6 | Nov 29, 2005 | — |
Showing 46 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- MESO (Nasdaq), MEOBF (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- Melbourne, Victoria, Australia
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1345099
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.